California counties sue over painkiller marketing

by Paul Elias

Two California counties have filed a lawsuit accusing five drug companies of waging a campaign of deception to boost the sales of painkillers behind the nation's prescription drug addiction problem.

Orange and Santa Clara counties filed the suit Wednesday in Orange County Superior Court, alleging false advertising, and creating a public nuisance.

The five companies are Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma, Actavis, Endo Health Solutions Inc., and Teva Pharmaceutical Industries' Cephalon Inc.

Much like the legal attack on tobacco companies two decades ago by many states, the current lawsuit accuses the of making misleading and false claims about the safety of products consumed annually by millions of Americans.

The lawsuit seeks to stop the marketing campaigns by the companies and demands unspecified damages.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Drug firms argue against $1.2B Arkansas judgment

Feb 27, 2014

(AP)—A lawyer for two drug companies told the Arkansas Supreme Court that the state improperly relied on federal regulations in a lawsuit that resulted in a $1.2 billion award over the companies' marketing of an antipsychotics ...

Teva says US is investigating Copaxone marketing

Feb 10, 2014

Teva Pharmaceutical Industries said Monday the federal government is investigating its marketing of its multiple sclerosis drug Copaxone and Parkinson's disease treatment Azilect.

Seattle taxi drivers sue ridesharing service

Mar 25, 2014

A Seattle-area taxi drivers organization has sued an app-based ridesharing service, alleging that Uber violates multiple laws and regulations, thus harming taxi drivers and the public.

Authorities in US sue Novartis in kickback scheme

Jan 09, 2014

Novartis Pharmaceuticals Corp. paid kickbacks to a specialty pharmacy in exchange for recommending refills of a blood transfusion drug it produces, according to an amended complaint filed Wednesday in a civil case brought ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

8 minutes ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments